Zacks Investment Research
News Agency

BAYRY Beats on Q2 Earnings, Crop Science Business Boosts Growth
Bayer tops Q2 estimates as Crop Science and fast-growing drugs offset pressure from patent-expired brands, while reaffirming its 2026 outlook.
Related Symbols
1
B
BAYRY
BAYRY
Source:
Zacks Investment Research
Visit Source
Comments